&Partners’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
&Partners's KYTX Position: Q3 2026 in Review
&Partners opened a new position in Kyverna Therapeutics (KYTX) in Q3 2026: 13,065 shares worth $88.8K. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings.
128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- &Partners held 13,065 shares of Kyverna Therapeutics worth $88.8K as of Q3 2026.
- Kyverna Therapeutics was a new &Partners position in Q3 2026.
- Kyverna Therapeutics made up ﹤0.01% of &Partners's portfolio in Q3 2026, its #2614 holding.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.